Export

EN
FR
Primaquine
Essential medicine status
Section:
6. Anti-infective medicines 6.5. Antiprotozoal medicines 6.5.3. Antimalarial medicines 6.5.3.1. Antimalarial medicines > For curative treatment
ATC codes: P01BA03
EMLc
Indication
Malaria due to Plasmodium vivax ICD11 code: 1F81
INN
Primaquine
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
Only for use to achieve radical cure of P. vivax and P. ovale infections, to be administered for 14 days
Formulations
Oral > Solid: 7.5 mg tablet (as phosphate) ; 15 mg tablet (as phosphate)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 2007 (TRS 946)
Changed in 2007 (TRS 950)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Primaquine
DrugBank
Primaquine
Summary of evidence and Expert Committee recommendations
Primaquine was added to the core list of the EMLc for the curative treatment of P. vivax.